Sunshine Biopharma completes a public offering valued at up to $20.4 million, including $6 million upfront and $14.4 million contingent on warrant exercises.

Observed price moves

• SBFM+1.75%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.